NCT06322043
Active, not recruiting
Not Applicable
A Single-Arm Pilot Study to Evaluate the Safety of Adipearl Injection in the Subcutaneous Tissues of Adults
Volumina Medical S.A.1 site in 1 country18 target enrollmentStarted: March 26, 2024Last updated:
Overview
- Phase
- Not Applicable
- Status
- Active, not recruiting
- Sponsor
- Volumina Medical S.A.
- Enrollment
- 18
- Locations
- 1
- Primary Endpoint
- Safety of Investigational Medical Device
Overview
Brief Summary
Adipearl is an injectable filler intended to be injected subcutaneously.
Study Design
- Study Type
- Interventional
- Allocation
- Na
- Intervention Model
- Single Group
- Primary Purpose
- Basic Science
- Masking
- None
Eligibility Criteria
- Ages
- 22 Years to 65 Years (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •Subject having given freely and expressly informed consent;
- •Subject deemed by the Investigator to be medically fit for injection of the product;
- •Female or male subjects aged 22 to 65 years (inclusive);
Exclusion Criteria
- •Pregnant or nursing woman or planning a pregnancy during the study.
- •Subject who had been deprived of their freedom by administrative or legal decision or who is under guardianship.
- •Subject participating to another research study.
- •Subject with the presence of any condition, which in the opinion of the Principal Investigator, that makes her/him unable to complete the study per protocol.
Outcomes
Primary Outcomes
Safety of Investigational Medical Device
Time Frame: 6-Months
Collection of Injection Site Reactions and Adverse Events during the study.
Secondary Outcomes
No secondary outcomes reported
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Active, not recruiting
Not Applicable
Clinical Investigation Evaluating the Safety and Feasibility of AdipearlMid-face Volume DeficiencyNCT06034522Volumina Medical S.A.18
Recruiting
Not Applicable
Safety of Adipose-derived Regenerative Cells Injection for Treatment of Osteoarthritis of the Facet JointOsteoarthritis of Facet Joint of Lumbar SpineNCT03513731InGeneron, Inc.40
Completed
Phase 1
Safety of NStride Autologous Protein Solution in the Treatment of Knee Osteoarthritis (PROGRESS I)Osteoarthritis, KneeNCT02262364Zimmer Biomet11
Completed
Not Applicable
Injection of Autologous Adipose Tissue for Treatment of Osteoarthritis in the KneeOsteo Arthritis KneeNCT03399630Aestique Medical Center8
Completed
Phase 1
Evaluate Safety of Adipose Derived Mesenchymal Stem Cell Transplantation for Type 1 Diabetes TreatmentType 1 DiabetesNCT05308836Vinmec Research Institute of Stem Cell and Gene Technology10